Statistics

Total Visits

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive62

Select a period of time:

Number of views in the range

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive44

Views

Views
February 20253
March 202516
April 20252
May 20252
June 20253
July 202518
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Brazil11
United States9
Argentina2
Egypt1
Spain1
United Kingdom1
Hong Kong1
Mexico1
Venezuela1
 

Top cities views

Views
São Paulo5
Buenos Aires1
Cairo1
Caracas1
Contagem1
Council Bluffs1
Cumming1
Feira de Santana1
Garanhuns1
Georgetown1